Author details

Full Name

Marco Salvetti

Affiliation

ORCID

Career Start Year

1988

Papers

258

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37535421	Quantitative sensory testing and skin biopsy findings in late-onset ATTRv presymptomatic carriers: Relationships with predicted time of disease onset (PADO).		2023
36336775	Distal upper limb involvement in myasthenia-myositis association.	Neurological Sciences	2023
36329184	Muscle MRI in immune-mediated necrotizing myopathyÂ (IMNM): implications for clinical management and treatment strategies.	Journal of Neurology	2023
37583699	Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis.		2023
37154406	Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?		2023
36969367	A specific anti-COVID-19 BNT162b2 vaccine-induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipients.		2023
36905818	Frailty and relapse activity in multiple sclerosis: A longitudinal observation.		2023
37334371	The value of Interferon Î² in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review.		2023
36764322	Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy.		2023
37311950	Comparison of quantitative muscle ultrasound and whole-body muscle MRI in facioscapulohumeral muscular dystrophy type 1 patients.		2023
37047023	Peripheral Biomarkers in Manifest and Premanifest Huntington's Disease.		2023
37232279	Sars-CoV2 infection in pregnant women with multiple sclerosis.		2023
35344079	Correction to: Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study.	Journal of Neurology	2022
35911920	Bridging Therapies With Injectable Immunomodulatory Drugs in the Management of Multiple Sclerosis: A Delphi Survey of an Italian Expert Panel of Neurologists.	Frontiers in Neurology	2022
35530174	Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach-perspectives from the International Progressive MS Alliance.	Multiple Sclerosis Journal - Experimental, Translational and Clinical	2022
35526306	Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy.	eBioMedicine	2022
35971322	Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register.	Multiple Sclerosis Journal	2022
35766209	Nerve high-resolution ultrasound in a 2-years follow-up of radial nerve palsy related to humeral shaft fractures.	Journal of Neurosurgical Sciences	2022
36293304	Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington's Disease: A Pilot Study.	International Journal of Molecular Sciences	2022
36288659	The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study.	Multiple Sclerosis and Related Disorders	2022
36086905	Signs and symptoms of COVID-19 in patients with multiple sclerosis.	European Journal of Neurology	2022
35636410	A Clinical and Epidemiological Prevalence Study on Friedreich's Ataxia in Latium, Italy.	Neuroepidemiology	2022
35877104	Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis.	JAMA Neurology	2022
36205784	The impact of cerebral vasomotor reactivity on cerebrovascular diseases and cognitive impairment.	Journal of Neural Transmission	2022
35735030	Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies.	Multiple Sclerosis Journal	2022
35675744	A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis.	Multiple Sclerosis and Related Disorders	2022
35359637	Secondary Prevention in Radiologically Isolated Syndromes and Prodromal Stages of Multiple Sclerosis.	Frontiers in Neurology	2022
35356454	Late-Onset MS: Disease Course and Safety-Efficacy of DMTS.	Frontiers in Neurology	2022
35979352	Proinflammatory mucosal-associated invariant CD8+ T cells react to gut flora yeasts and infiltrate multiple sclerosis brain.	Frontiers in Immunology	2022
35785358	Feasibility, Safety, and Effectiveness of Telerehabilitation in Mild-to-Moderate Parkinson's Disease.	Frontiers in Neurology	2022
35723265	Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients.	Multiple Sclerosis Journal	2022
35534508	Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome.	Scientific Reports	2022
36530641	CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review.		2022
33851318	Different Susceptibility of T and B Cells to Cladribine Depends On Their Levels of Deoxycytidine Kinase Activity Linked to Activation Status.	Journal of NeuroImmune Pharmacology	2022
33784961	Drugs Used in the Treatment of Multiple Sclerosis During COVID-19 Pandemic: A Critical Viewpoint.	Current Neuropharmacology	2022
34189665	Skin biopsy and quantitative sensory assessment in an Italian cohort of ATTRv patients with polyneuropathy and asymptomatic carriers: possible evidence of early non-length dependent denervation.	Neurological Sciences	2022
34328824	SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study.	Multiple Sclerosis Journal	2022
34923946	Vaccination Opportunities in Multiple Sclerosis Patients Treated with Cladribine Tablets.	Current Neuropharmacology	2022
34802089	High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP.	Neurological Sciences	2022
34735749	The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis.	European Journal of Neurology	2022
34850641	Charting a global research strategy for progressive MS-An international progressive MS Alliance proposal.	Multiple Sclerosis Journal	2022
34490928	MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis.	Neuropathology and Applied Neurobiology	2022
35158459	Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in the real-world setting: Interim results from the Plegridy Observational Program.	Multiple Sclerosis and Related Disorders	2022
35000469	Response to "Frailty in multiple sclerosis: A closer look at the deficit accumulation framework".	Multiple Sclerosis Journal	2022
34590902	ADEM after ChAdOx1 nCoV-19 vaccine: A case report.	Multiple Sclerosis Journal	2022
35305331	Epstein-Barr virus and multiple sclerosis: supporting causality.	Lancet Neurology, The	2022
34646278	Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?	Frontiers in Immunology	2021
32339291	Cochlear Implantation in Neurological Patients: Case Report and Literature Survey.	Laryngoscope	2021
34240579	DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France.	Annals of Clinical and Translational Neurology	2021
33638679	Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up.	Journal of Neurology	2021